Multimodal Approach and its Impact on Survival for Patients with Hepatocellular Carcinoma

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 4047-4053

  Bassanello, Marco ^a   Cillo, Umberto ^a   Vitale, Alessandro ^a   Lumachi, Franco ^a   Ciarleglio, Francesco A ^a   Boccagni, Patrizia ^a   Brolese, Alberto ^a   Zanus, Giacomo ^a   D'Amico, Francesco ^a   Senzolo, Marco ^a   D'Amico, Davide Francesco ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Liver transplantation; Multimodal therapy

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 10744221397     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. El Serag HB and Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340: 745-750, 1999.
2. Bruix J and Llovet JM: Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 35: 519-524, 2002.
3. Bruix J, Sherman M, Llovet JM, Beaugrand M et al: Clinical management of hepatocellular carcinoma. Conclusion of the Barcellona 2000 EASL Conference. J Hepatol 35: 421-430, 2001.
4. Pugh RNH, Murray-Lyon IM, Dawson JL et al: Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60: 646-664, 1973.
5. Izumi R, Shimizu K, Ii T et al: Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 106: 720-727, 1994.
6. Okuda K, Othtsuki T, Obata H et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56: 918-928, 1985.
7. Koda M, Murawaki Y, Mitsuda A, Ikawa S et al: Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma. Cancer 88: 529-537, 2000.
8. Christians KK, Pitt HA, Rilling WS et al: Hepatocellular carcinoma: Multimodality management. Surgery 130: 554-560, 2001.
9. Marcos-Alvarez A, Jenkins RL, Washburn WK et al: Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg 131: 292-298, 1996.
10. Liu CL and Fan ST: Nonresectional therapies for hepatocellular carcinoma. Am J Surg 173: 358-365, 1997.
11. Tamura S, Kato T, Berho M et al: Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 136: 25-30, 2001.
12. Shimada M, Takenaka K, Gion T, Sugimachi K et al: Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 111: 720-726, 1996.
13. Poon RT, Fan ST, Lo CM et al: Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229: 216-222, 1999.
14. Poon RT, Fan ST, Ng IO et al: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 89: 500-507, 2000.
15. Majno PE, Adam R, Bismuth H et al: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 226: 688-703, 1997.
16. Tanaka K, Shimada H, Togo S et al: Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepatogastroenterology 46: 1083-1088, 1999.
17. Curley SA, Izzo F, Ellis LM et al: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 232: 381-391, 2000.
18. Pearson AS, Izzo F, Fleming RY et al.: Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 178: 592-599, 1999.
19. Bismuth H, Chiche L, Adam R et al: Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 218: 145-151, 1993.
20. Mazzaferro V, Regalia E, Doci R et al: Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699, 1996.
21. Figueras J, Jaurrieta E, Valls C et al: Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25: 1485-1489, 1997.
22. Salizzoni M, Zamboni F, Lupo F et al: Liver transplantation for early-detected, multifocal hepatocellular carcinoma. Br J Surg 88: 1194-1195, 2001.
23. Yao FY, Ferrel L, Bass NM et al: Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-1403, 2001.
24. Roayaie S, Frischer JS, Miller CM et al: Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg 235: 533-539, 2002.
25. Troisi R, Defreyne L, Hesse UJ et al: Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation. Clin Transplant 12: 313-319, 1998.